... infiltration over 3 mm may prompt RHC consideration. However, current evidence suggests that long-term outcome is not affected by the extent of surgery in aNETs 1–2 cm in size questioning the necessity of RHC in these cases. Advanced metastatic aNETs, extremely rare in occurrence, follow treatment guidelines...

... the availability of direct-acting antivirals (DAA), HCV treatment has changed significantly. Current treatment strategies for different groups of patients as well as potential risks and caveats will be discussed in this review. Summary: Interferon-free (IFN-free) treatment not only shortens treatment duration...

... stages at diagnosis. Thus, screening colonoscopy is effective in the early diagnosis not only of colorectal adenomas and adenocarcinomas but also of rectal NET. Endoscopic resection is the treatment of choice in NET G1 of the stomach, duodenum (despite gastrinoma), and rectum that are ≤10 mm in size, do...

..., such as peptic ulcer disease, gastric cancer, and gastric mucosa-associated lymphoid tissue lymphoma. Treatment of H. pylori is facing an increasing number of failures, with the main reason being an increasing antibiotic resistance to some of the previously most effective antibiotics, i.e. clarithromycin...

... Inflammation Insulin resistance Treatment NASH patients commonly present with metabolic inflammation which is mirrored by elevated levels of high-sensitivity C-reactive protein, ferritin, or interleukin (IL)-1 receptor antagonist serum levels. It is currently not understood why certain NAFLD...

... review we discuss the impact of these developments on the prevention of HCC as well as the treatment of patients with HCC. Methods: Studies indexed in Medline between 1990 and 2015 (November) were reviewed. The terms ‘hepatocellular carcinoma', ‘HCC', ‘hepatitis B', ‘hepatitis C', ‘viral hepatitis...